RHON-KLINIKUM AG Unsponsored ADR
RKAGYOTCHealthcare● Active
$8.16
+$0.00(+0.00%)
Market Cap$1.1B
P/E Ratio—
52W High$8.16
52W Low$7.31
RHON-KLINIKUM AG Unsponsored ADR (RKAGY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RKAGY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.86B | $1.60B | $1.46B | $1.45B | $1.59B |
| Cost of Revenue | $1.70B | $1.42B | $1.32B | $0.45B | $0.43B |
| Gross Profit | $0.16B | $0.17B | $0.15B | $1.00B | $0.18B |
| Gross Margin %(computed) | 8.67% | 10.77% | 10.16% | 69.12% | 11.48% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.07B | $0.07B | $0.02B | $0.02B |
| Total Operating Expenses | $0.16B | $0.12B | $0.11B | $0.96B | $0.15B |
| Operating Income | $0.00B | $0.05B | $0.04B | $0.04B | $0.03B |
| Operating Margin %(computed) | 0.23% | 3.02% | 2.76% | 2.50% | 1.92% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.04B | $0.06B | $0.05B | $0.03B | $0.03B |
| Income Tax Expense | $0.01B | $0.01B | $0.01B | $0.01B | ($0.00B) |
| Net Income | $0.03B | $0.04B | $0.04B | $0.03B | $0.03B |
| Net Margin %(computed) | 1.78% | 2.72% | 2.64% | 1.74% | 1.78% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.25 | $0.34 | $0.29 | $0.19 | $0.21 |
| Wtd Avg Shares | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B |
| EBITDA | $0.07B | $0.12B | $0.12B | $0.10B | $0.10B |
| EBITDA Margin %(computed) | 3.59% | 7.66% | 7.99% | 6.75% | 6.31% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B
Explore more RHON-KLINIKUM AG Unsponsored ADR data
About RHON-KLINIKUM AG Unsponsored ADR (RKAGY) Income Statement
RHON-KLINIKUM AG Unsponsored ADR (RKAGY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RKAGY reported revenue of $1.86B, gross profit of $0.16B (gross margin 8.67%), and net income of $0.03B — a net profit margin of 1.78%.
Frequently asked questions
RKAGY · 4 questionsRHON-KLINIKUM AG Unsponsored ADR (RKAGY) reported revenue of $1.86B for 2025, up 16.5% year-over-year.
RKAGY revenueRKAGY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09